Lasa Supergenerics Ltd. (LASA)
Market Closed
11 Aug, 22:00
MSE MSE Primary XNSE ₹
7. 69
-0.15
-1.9133%
₹
323.15M Market Cap
- P/E Ratio
- Div Yield
4,916 Volume
0 Eps
₹ 7.84
Previous Close Want to track LASA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
LASA closed today lower at ₹7.69, a decrease of -1.9133% from yesterday's close, completing a monthly increase of 1.1842% or ₹0.09. Over the past 12 months, LASA stock lost -24.5339%.
LASA is not paying dividends to its shareholders.
The last earnings report, released on Jun 01, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.17%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on MSE (INR).
LASA Chart
People also search for
Lasa Supergenerics Ltd. (LASA) FAQ
What is the stock price today?
The current price is ₹7.69.
On which exchange is it traded?
Lasa Supergenerics Ltd. is listed on MSE.
What is its stock symbol?
The ticker symbol is LASA.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 323.15M.
Has Lasa Supergenerics Ltd. ever had a stock split?
No, there has never been a stock split.
Lasa Supergenerics Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Dr. Omkar Pravin Herlekar CEO | MSE Exchange | Y5S74C106 CUSIP |
| India Country | 66 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Lasa Supergenerics Limited is a prominent player in the pharmaceutical industry, focusing on the research, production, and distribution of healthcare products for both animal and human markets primarily within India. Founded in 2016 and headquartered in Ratnagiri, India, the company has carved out a niche for itself by specializing in the development of Active Pharmaceutical Ingredients (APIs) and other critical healthcare products. With a strong emphasis on quality and innovation, Lasa Supergenerics not only caters to the domestic market but also serves international clients through its export operations.
Products and Services
Lasa Supergenerics Limited offers a diverse range of products and services tailored to meet the needs of the healthcare industry. The company's product portfolio includes:
- API Products: The company specializes in manufacturing several key API products necessary for the production of various drugs. These include:
- Fenbendazole - An anthelmintic drug used to treat parasitic worm infections.
- Toldimphos Sodium - Often used as a nutritional supplement in veterinary medicine.
- Cyromazine - A triazine insect growth regulator used to control dipterous larvae.
- Albendazole, Riclabendazole, Rafoxanide, Ornidazole, Ricobendazole, Oxfendazole - A range of anthelmintic drugs for treating parasitic worm infestations.
- Closantel Base, Closantel Sodium - Salicylanilide anthelmintic drugs effective against a variety of parasites.
- Nitroxynil - A phenol derivative used as an anthelmintic.
- Halquinol - A drug used as an antimicrobial agent.
- Oxyclozanide - A salicylanilide anthelmintic drug.
- 2,6-Diiodo-4-nitrophenol - An organic compound with various pharmaceutical applications.
- Other API Products: In addition to the main APIs, the company also produces various other API products to cater to the broader requirements of the pharmaceutical industry.
- Animal Feed Ingredients: Recognizing the importance of nutrition in animal health, Lasa Supergenerics offers high-quality animal feed ingredients such as calcium iodate to support the wellbeing of livestock.
- Reagents for Therapeutic Use: The company provides essential reagents like potassium iodide, which are crucial for various therapeutic applications in healthcare.
Contact Information
Address: Plot no. C-4
Phone: 91 77 9888 8188
Website: https://lasalabs.com
